Alessandro Roberto Dodesini

3.1k total citations · 1 hit paper
25 papers, 1.6k citations indexed

About

Alessandro Roberto Dodesini is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Nephrology. According to data from OpenAlex, Alessandro Roberto Dodesini has authored 25 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Surgery and 8 papers in Nephrology. Recurrent topics in Alessandro Roberto Dodesini's work include Diabetes Treatment and Management (8 papers), Diabetes Management and Research (7 papers) and Gestational Diabetes Research and Management (7 papers). Alessandro Roberto Dodesini is often cited by papers focused on Diabetes Treatment and Management (8 papers), Diabetes Management and Research (7 papers) and Gestational Diabetes Research and Management (7 papers). Alessandro Roberto Dodesini collaborates with scholars based in Italy, Sweden and Slovenia. Alessandro Roberto Dodesini's co-authors include Roberto Trevisan, Giuseppe Lepore, Giuseppe Remuzzi, Ilian Iliev, Aneliya Parvanova, Antonio Bossi, Flavio Gaspari, Annalisa Perna, Nadia Rubis and Bogdan Ene‐Iordache and has published in prestigious journals such as New England Journal of Medicine, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

Alessandro Roberto Dodesini

24 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Preventing Microalbuminuria in Type 2 Diabetes

2004 680 citations Piero Ruggenenti, Anna Fassi et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Alessandro Roberto Dodesini

Since Specialization

Citations

This map shows the geographic impact of Alessandro Roberto Dodesini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandro Roberto Dodesini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandro Roberto Dodesini more than expected).

Fields of papers citing papers by Alessandro Roberto Dodesini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessandro Roberto Dodesini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandro Roberto Dodesini. The network helps show where Alessandro Roberto Dodesini may publish in the future.

Co-authorship network of co-authors of Alessandro Roberto Dodesini

This figure shows the co-authorship network connecting the top 25 collaborators of Alessandro Roberto Dodesini. A scholar is included among the top collaborators of Alessandro Roberto Dodesini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessandro Roberto Dodesini. Alessandro Roberto Dodesini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Rare forms of monogenic diabetes in non-European individuals. First reports of CEL and RFX6 mutations from the Indian subcontinent 2024 ·Acta Diabetologica ·(unknown), Claudia Menzaghi, Alessandro Roberto Dodesini, Mascia Albizzi, Angelo Acquafredda, G. Fini, Vincenzo Trischitta, Rosa Di Paola	1
2	Advanced Hybrid Closed-Loop System Achieves and Maintains Recommended Time in Range Levels for Up To 2 Years: Predictors of Best Efficacy 2023 ·Diabetes Technology & Therapeutics ·Giuseppe Lepore, (unknown), (unknown), Silvia Ippolito, (unknown), A. Corsi, Cristiana Scaranna, Alessandro Roberto Dodesini, Rosalia Bellante, Roberto Trevisan	9
3	Development of a New Model of Insulin Sensitivity in Patients With Type 2 Diabetes and Association With Mortality 2023 ·The Journal of Clinical Endocrinology & Metabolism ·Stefano Ciardullo, Alessandro Roberto Dodesini, Giuseppe Lepore, A. Corsi, Cristiana Scaranna, Gianluca Perseghin, Roberto Trevisan	5
4	Switching to the Minimed™ 780G system achieves clinical targets for CGM in adults with type 1 diabetes regardless of previous insulin strategy and baseline glucose control 2022 ·Acta Diabetologica ·Giuseppe Lepore, Alessandro Rossini, Rosalia Bellante, A. Corsi, Cristiana Scaranna, Alessandro Roberto Dodesini, Roberto Trevisan	21
5	Identification of the Inappropriate Clinical Actions (DON'T) to Improve the Management of Patients with Type 2 Diabetes Failing Basal Insulin Supported Oral Treatment: Results of Survey for a Panel of Diabetes Specialists in Italy 2021 ·Diabetes Therapy ·Gaetano Leto, Ilaria Barchetta, (unknown), (unknown), (unknown), Roberta Manti, Carlo Negri, Vincenzo Cimino, Alessandro Roberto Dodesini, (unknown), Roberto Baratta	1
6	Resilience in pregnant women with pre-gestational diabetes during COVID-19 pandemic: the experience of the Papa Giovanni XXIII Hospital in Bergamo, Italy 2020 ·Acta Diabetologica ·Alessandro Roberto Dodesini, (unknown), Maria Simonetta Spada, Roberto Trevisan	1
7	Switching from Suspend-Before-Low Insulin Pump Technology to a Hybrid Closed-Loop System Improves Glucose Control and Reduces Glucose Variability: A Retrospective Observational Case–Control Study 2019 ·Diabetes Technology & Therapeutics ·Giuseppe Lepore, Cristiana Scaranna, A. Corsi, Alessandro Roberto Dodesini, Roberto Trevisan	19
8	Impact of a Complement Factor H Gene Variant on Renal Dysfunction, Cardiovascular Events, and Response to ACE Inhibitor Therapy in Type 2 Diabetes 2019 ·Frontiers in Genetics ·Elisabetta Valoti, Marina Noris, Annalisa Perna, Erica Rurali, Giulia Gherardi, Matteo Breno, Aneliya Parvanova, Ilian Iliev, Antonio Bossi, Roberto Trevisan, Alessandro Roberto Dodesini, Silvia Ferrari, Nadia Stucchi, Ariela Benigni, Giuseppe Remuzzi, Piero Ruggenenti	9
9	“MySweetGestation”: A novel smartphone application for women with or at risk of diabetes during pregnancy 2019 ·Diabetes Research and Clinical Practice ·Andrea Tumminia, Ester Vitacolonna, Laura Sciacca, Alessandro Roberto Dodesini, (unknown), Cristina Lencioni, (unknown), Basilio Pintaudi, Marina Scavini, Elena Succurro, Elisabetta Torlone, Angela Napoli	4
10	Effects of a low glycemic index high in fiber diet on blood glucose in women with gestational diabetes 2019 ·The Journal of Maternal-Fetal & Neonatal Medicine ·Alessandro Roberto Dodesini, (unknown), Elena Ciriello, (unknown), Luisa Patanè, (unknown), (unknown), Roberto Trevisan	1
11	The risk stratification of adverse neonatal outcomes in women with gestational diabetes (STRONG) study 2018 ·Acta Diabetologica ·(unknown), Basilio Pintaudi, (unknown), (unknown), Alessandro Roberto Dodesini, Ester Vitacolonna, Andrea Tumminia, Laura Sciacca, Cristina Lencioni, (unknown), Giuseppe Lucisano, Antonio Nicolucci, Matteo Bonomo, Angela Napoli	60
12	Review of general suggestions on physical activity to prevent and treat gestational and pre-existing diabetes during pregnancy and in postpartum 2018 ·Nutrition Metabolism and Cardiovascular Diseases ·Nicolina Di Biase, Stefano Balducci, Cristina Lencioni, (unknown), Andrea Tumminia, Alessandro Roberto Dodesini, Basilio Pintaudi, (unknown), Ester Vitacolonna, Angela Napoli	20
13	The Hyperfiltering Kidney in Diabetes 2016 ·The Nephron journals/Nephron journals ·Roberto Trevisan, Alessandro Roberto Dodesini	27
14	Level of implementation of guidelines on screening and diagnosis of gestational diabetes: A national survey 2016 ·Diabetes Research and Clinical Practice ·Basilio Pintaudi, (unknown), (unknown), (unknown), Alessandro Roberto Dodesini, Angela Napoli, Matteo Bonomo	10
15	Measurable Urinary Albumin Predicts Cardiovascular Risk among Normoalbuminuric Patients with Type 2 Diabetes 2012 ·Journal of the American Society of Nephrology ·Piero Ruggenenti, Esteban Porrini, Nicola Motterlini, Annalisa Perna, Aneliya Parvanova, Ilian Iliev, Alessandro Roberto Dodesini, Roberto Trevisan, Antonio Bossi, Giuseppe Sampietro, (unknown), Flavio Gaspari, Nadia Rubis, Bogdan Ene‐Iordache, Giuseppe Remuzzi	64
16	Continuous subcutaneous insulin infusion is more effective than multiple daily insulin injections in preventing albumin excretion rate increase in Type 1 diabetic patients 2009 ·Diabetic Medicine ·Giuseppe Lepore, Daniela Bruttomesso, M. Bonomo, Alessandro Roberto Dodesini, Silvana Costa, Elena Meneghini, A. Corsi, I Nosari, Roberto Trevisan	9
17	Lipids and Renal Disease 2006 ·Journal of the American Society of Nephrology ·Roberto Trevisan, Alessandro Roberto Dodesini, Giuseppe Lepore	196
18	Preventing Microalbuminuria in Type 2 Diabetes breakdown → 2004 ·New England Journal of Medicine ·Piero Ruggenenti, Anna Fassi, Aneliya Parvanova, Simona Bruno, Ilian Iliev, (unknown), Nadia Rubis, Giulia Gherardi, (unknown), María Ganeva, Bogdan Ene‐Iordache, Flavio Gaspari, Annalisa Perna, Antonio Bossi, Roberto Trevisan, Alessandro Roberto Dodesini, Giuseppe Remuzzi	680
19	Effect of sodium intake on blood pressure and albuminuria in Type 2 diabetic patients: the role of insulin resistance 2003 ·Diabetologia ·Monica Vedovato, Giuseppe Lepore, Anna Coracina, Alessandro Roberto Dodesini, (unknown), Antonio Tiengo, Stefano Del Prato, Roberto Trevisan	121
20	Effectiveness and safety of multidrug intracavernous therapy for vasculogenic impotence 1993 ·Urology ·Francesco Montorsi, Giorgio Guazzoni, F. Bergamaschi, Alessandro Roberto Dodesini, Patrizio Rigatti, G. Pizzini, A Miani	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact